Skip to content

Low-frequency acupuncture combined with ear acupressure for allergic rhinitis: a non-inferiority randomized controlled trial

Low-frequency acupuncture combined with ear acupressure for allergic rhinitis: a non-inferiority randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072505
Enrollment
Unknown
Registered
2023-06-15
Start date
2023-06-05
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Treatment group:low-frequency acupuncture combined with ear acupressure
Control group:high-frequency acupuncture

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for moderate to severe persistent allergic rhinitis; 2. History of moderate to severe persistent allergic rhinitis = 2 years; 3. The total nasal symptom score (TNSS) = 4 points before treatment 1 week ago; 4. The age ranged from 18 to 65 years; 5. Subjects agree to join the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of chronic sinusitis or chronic sinusitis detected by sinonasal X-ray examination; 2.Patients with organic lesions in nasal cavity or undergoing nasal surgery; 3.Patients with respiratory tract infection or acute sinusitis, or with inflammation on chest X-ray within the past 2 weeks; 4.Patients who had received western medicine (H1-antihistamines, glucocorticoids, leukotriene receptor antagonists, mast cell membrane stabilizers, decongestants and anticholinergic drugs, etc.) or traditional Chinese medicine (TCM) through nasal, oral or systemic route within the past 2 weeks; 5.Patients who had received acupuncture, moxibustion, pot, intranasal Chinese medicine inhalation and other physical therapies within the scope of traditional Chinese medicine and other traditional medicine within the past 2 weeks; 6.Patients who had received specific immunotherapy or systemic hormonal therapy within the previous year; 7.Patients with severe respiratory system diseases, cardiovascular and cerebrovascular diseases, liver, spleen, kidney and hematopoietic system diseases, mental diseases and infectious diseases; 8.Women who were pregnant, lactating, or planned to become pregnant during the trial; 9.The presence of any contraindications to acupuncture, scarring or infection at the surgical site, or systemic illness at the surgical site considered by the investigator to be inappropriate for intervention; 10.Allergic to treatment devices such as stainless steel, the seed of cowherb, and adhesive tape; 11.Patients identified by the investigator as unable to cooperate with treatment

Design outcomes

Primary

MeasureTime frame
Total nasal symptom score;

Secondary

MeasureTime frame
Total nonnasal symptom score;Total ocular symptom score;Rhinoconjunctivitis quality of life questionnaire;Rhinitis control assessment test;Rescue medication score;Duration of response;Number of days of rhinitis onset;Acupuncture expectancy scale;Patient acceptance and satisfaction;Adverse events;

Countries

China

Contacts

Public ContactZHAO Ji-ping

Dongzhimen Hospital, Beijing University of Chinese Medicine

zjp7883@sina.com+86 136 2138 2136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026